Evidence map›Paper›PMID 26215161›Full record

ArticleBMC biology2015

Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5.

Jade Louber, Joanna Brunel, Emiko Uchikawa, Stephen Cusack, Denis Gerlier

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Cellular origins of dsRNA, their recognition and consequences.Nature reviews. Molecular cell biology · 2022
    Review
  11. Review
  12. Role of Mitochondria in Viral Infections.Life (Basel, Switzerland) · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jade LouberCIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France. jade.louber@gmail.com.
Joanna BrunelCIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France. Joanna.brunel@inserm.fr.
Emiko UchikawaEuropean Molecular Biology Laboratory, Grenoble Outstation, 71 Avenue des Martyrs, BP 181, 38042, Grenoble, Cedex 9, France. uchikawa@embl.fr.
Stephen CusackEuropean Molecular Biology Laboratory, Grenoble Outstation, 71 Avenue des Martyrs, BP 181, 38042, Grenoble, Cedex 9, France. cusack@embl.fr.
Denis GerlierCIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France. denis.gerlier@inserm.fr.
European Molecular Biology Laboratory · FRUniversité Claude Bernard Lyon 1 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe cytoplasmic RIG-like receptors are responsible for the early detection of viruses and other intracellular microbes by activating the innate immune response mediated by type I interferons (IFNs). RIG-I and MDA5 detect virus-specific RNA motifs with short 5'-tri/diphosphorylated, blunt-end double-stranded RNA (dsRNA) and >0.5-2 kb long dsRNA as canonical agonists, respectively. However, in vitro, they can bind to many RNA species, while in cells there is an activation threshold. As SF2 helicase/ATPase family members, ATP hydrolysis is dependent on co-operative RNA and ATP binding. Whereas simultaneous ATP and cognate RNA binding is sufficient to activate RIG-I by releasing autoinhibition of the signaling domains, the physiological role of the ATPase activity of RIG-I and MDA5 remains controversial.

resultsA cross-analysis of a rationally designed panel of RNA binding and ATPase mutants and truncated receptors, using type I IFN promoter activation as readout, allows us to refine our understanding of the structure-function relationships of RIG-I and MDA5. RNA activation of RIG-I depends on multiple critical RNA binding sites in its helicase domain as confirmed by functional evidence using novel mutations. We found that RIG-I or MDA5 mutants with low ATP hydrolysis activity exhibit constitutive activity but this was fully reverted when associated with mutations preventing RNA binding to the helicase domain. We propose that the turnover kinetics of the ATPase domain enables the discrimination of self/non-self RNA by both RIG-I and MDA5. Non-cognate, possibly self, RNA binding would lead to fast ATP turnover and RNA disassociation and thus insufficient time for the caspase activation and recruitment domains (CARDs) to promote downstream signaling, whereas tighter cognate RNA binding provides a longer time window for downstream events to be engaged.

conclusionsThe exquisite fine-tuning of RIG-I and MDA5 RNA-dependent ATPase activity coupled to CARD release allows a robust IFN response from a minor subset of non-self RNAs within a sea of cellular self RNAs. This avoids the eventuality of deleterious autoimmunity effects as have been recently described to arise from natural gain-of-function alleles of RIG-I and MDA5.

Indexed as

Adenosine TriphosphatasesAdenosine TriphosphateBinding SitesCell LineDEAD Box Protein 58DEAD-box RNA HelicasesHumansHydrolysisInterferon-Induced Helicase, IFIH1Keratin-8KineticsPoint MutationProtein BindingProtein Structure, TertiaryReceptors, ImmunologicRNA, Double-StrandedAdenosine TriphosphatasesAdenosine TriphosphateDEAD Box Protein 58DEAD-box RNA HelicasesIFIH1 protein, humanInterferon-Induced Helicase, IFIH1Keratin-8KRT8 protein, humanReceptors, ImmunologicRIGI protein, humanRNA, Double-Stranded

Identifiers

PMID26215161
PMCPMC4517655
OpenAlexW1886265516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.